Russell Barrans insider trades: Evofem Biosciences (EVFM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Russell reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 11, 2021 | EVFM | ↑ Buy | 18,180 | $1.14 | $21K | Direct | Jun 11, 2021 (0d) |
| Sep 11, 2020 | EVFM | ↑ Buy | 4,000 | $2.24 | $9K | Direct | Sep 11, 2020 (0d) |
| Feb 19, 2020 | EVFM | ↓ Sell | 14,957 | $6.50 | $97K | Direct | Feb 21, 2020 (2d) |
| Jan 16, 2020 | EVFM | ↓ Sell | 1,578 | $6.50 | $10K | Direct | Jan 21, 2020 (5d) |
| Nov 21, 2018 | EVFM | ↑ Buy | 279 | $3.55 | $990 | As custodian for child's UTMA account | Nov 26, 2018 (5d) |
| Aug 10, 2018 | EVFM | ↑ Buy | 3,715 | $1.98 | $7K | Direct | Aug 13, 2018 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Russell Barrans's insider trades
Russell Barrans is Chief Commercial Officer at Evofem Biosciences (EVFM). Since Aug 10, 2018, Russell has reported 4 open-market purchases worth $38K and 2 sales worth $107K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares withheld for taxes (13 filings), grants and awards (9 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EVFM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.